このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Tandem Diabetes Care マネジメント
マネジメント 基準チェック /44
Tandem Diabetes Care'sの CEO はJohn Sheridanで、 Apr2013年に任命され、 の在任期間は 11.17年です。 の年間総報酬は$ 4.65Mで、 15.3%給与と84.7%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.071%を直接所有しており、その価値は$ 2.21M 。経営陣と取締役会の平均在任期間はそれぞれ4.7年と3.9年です。
主要情報
John Sheridan
最高経営責任者
US$4.7m
報酬総額
| CEO給与比率 | 15.3% |
| CEO在任期間 | 11.2yrs |
| CEOの所有権 | 0.07% |
| 経営陣の平均在職期間 | 4.7yrs |
| 取締役会の平均在任期間 | 3.9yrs |
経営陣の近況
Recent updates
Is Tandem Diabetes Care (NASDAQ:TNDM) Weighed On By Its Debt Load?
Jun 18
Tandem Diabetes Care: Recent Rally Fully Deserved, Likely More Upside Here
May 29Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) 26% Jump Shows Its Popularity With Investors
May 10A Look At The Fair Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
May 04At US$30.10, Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Worth Looking At Closely?
Mar 26Even With A 27% Surge, Cautious Investors Are Not Rewarding Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Performance Completely
Mar 08Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?
Feb 22Estimating The Intrinsic Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Jan 14Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock Rockets 63% But Many Are Still Ignoring The Company
Dec 27Is It Too Late To Consider Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM)?
Nov 12Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Intrinsic Value Is Potentially 53% Above Its Share Price
Oct 06Does Tandem Diabetes Care (NASDAQ:TNDM) Have A Healthy Balance Sheet?
Sep 17Should You Think About Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Now?
Aug 08Calculating The Intrinsic Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Jul 03Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt Sensibly?
Jun 13Cautious Investors Not Rewarding Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Performance Completely
May 06Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?
Jan 04Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Potentially Undervalued?
Oct 15Tandem Diabetes Care: Overpriced, Underdelivering
Sep 22An Intrinsic Calculation For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Suggests It's 50% Undervalued
Sep 10Tandem Diabetes stock falls 10% on disappointing Q2 result
Aug 03Tandem Diabetes Care acquires Capillary Biomedical; terms undisclosed
Jul 21Tandem Diabetes Care: Strong Financials And Revenue, Overpenalized For Missed Earnings
Jul 08Tandem Diabetes Care (NASDAQ:TNDM) Is Looking To Continue Growing Its Returns On Capital
Jun 20Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Intrinsic Value Is Potentially 43% Above Its Share Price
May 30Here's Why Tandem Diabetes Care (NASDAQ:TNDM) Can Manage Its Debt Responsibly
Apr 17CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$141m |
| Dec 31 2023 | US$5m | US$711k | -US$223m |
| Sep 30 2023 | n/a | n/a | -US$208m |
| Jun 30 2023 | n/a | n/a | -US$224m |
| Mar 31 2023 | n/a | n/a | -US$204m |
| Dec 31 2022 | US$6m | US$711k | -US$95m |
| Sep 30 2022 | n/a | n/a | -US$68m |
| Jun 30 2022 | n/a | n/a | -US$13m |
| Mar 31 2022 | n/a | n/a | US$6m |
| Dec 31 2021 | US$6m | US$690k | US$16m |
| Sep 30 2021 | n/a | n/a | US$22m |
| Jun 30 2021 | n/a | n/a | US$7m |
| Mar 31 2021 | n/a | n/a | -US$25m |
| Dec 31 2020 | US$4m | US$600k | -US$34m |
| Sep 30 2020 | n/a | n/a | -US$49m |
| Jun 30 2020 | n/a | n/a | -US$42m |
| Mar 31 2020 | n/a | n/a | -US$17m |
| Dec 31 2019 | US$11m | US$500k | -US$25m |
| Sep 30 2019 | n/a | n/a | -US$24m |
| Jun 30 2019 | n/a | n/a | -US$55m |
| Mar 31 2019 | n/a | n/a | -US$113m |
| Dec 31 2018 | US$2m | US$386k | -US$123m |
| Sep 30 2018 | n/a | n/a | -US$138m |
| Jun 30 2018 | n/a | n/a | -US$119m |
| Mar 31 2018 | n/a | n/a | -US$82m |
| Dec 31 2017 | US$596k | US$375k | -US$73m |
報酬と市場: Johnの 総報酬 ($USD 4.65M ) は、 US市場 ($USD 6.76M ) の同様の規模の企業の平均を下回っています。
報酬と収益: Johnの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
John Sheridan (69 yo)
11.2yrs
在職期間
US$4,651,603
報酬
Mr. John F. Sheridan has been President and Chief Executive Officer at Tandem Diabetes Care, Inc., since March 01, 2019 and served as its Chief Operating Officer and Executive Vice President since April 20...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 11.2yrs | US$4.65m | 0.071% $ 2.0m | |
| Executive VP | 6.4yrs | US$1.25m | 0.048% $ 1.3m | |
| Executive VP & Chief Administrative Officer | 10.8yrs | US$1.25m | 0.034% $ 935.6k | |
| Transitional Advisor | less than a year | US$1.25m | 0.011% $ 299.0k | |
| Executive Officer | 8.3yrs | US$1.27m | 0.021% $ 569.3k | |
| Executive Vice President and Chief Strategy & Product Officer | 3yrs | US$1.25m | 0.018% $ 503.2k | |
| Executive VP & Chief Commercial Officer | less than a year | US$2.72m | データなし | |
| Chief Technical Officer | 2.6yrs | データなし | 0.017% $ 470.0k | |
| Executive VP | 2.4yrs | データなし | 0.016% $ 443.2k | |
| Chief Human Resources Officer | 6.8yrs | データなし | データなし | |
| Chief Medical Officer | less than a year | データなし | データなし | |
| Chief Manufacturing Officer | 6.8yrs | データなし | 0.026% $ 722.9k |
4.7yrs
平均在職期間
55yo
平均年齢
経験豊富な経営陣: TNDMの経営陣は 経験豊富 であると考えられます ( 4.7年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 5yrs | US$4.65m | 0.071% $ 2.0m | |
| Independent Chairwoman of the Board | 5.4yrs | US$222.78k | 0.015% $ 402.5k | |
| Chair Emeritus | less than a year | US$198.78k | 0.35% $ 9.6m | |
| Independent Director | 10.9yrs | US$200.95k | 0.037% $ 1.0m | |
| Independent Director | 16.9yrs | US$214.67k | 0.070% $ 1.9m | |
| Independent Director | 3.8yrs | US$190.28k | 0.026% $ 714.8k | |
| Independent Director | 3.4yrs | US$189.25k | 0.017% $ 476.9k | |
| Independent Director | 4yrs | US$189.25k | 0.021% $ 576.8k | |
| Independent Director | 2yrs | US$176.55k | 0.0090% $ 249.0k | |
| Independent Director | 2yrs | US$177.55k | 0.0090% $ 249.0k |
3.9yrs
平均在職期間
61.5yo
平均年齢
経験豊富なボード: TNDMの 取締役会 は 経験豊富 であると考えられます ( 3.9年の平均在任期間)。